so given this rejection, does this meant that NSB has zero chance of allowing emtinB to progress further, and the study into EmtinB is now dead?
NSB can still survive but they have to find a new piece of biology to work with?
Or does emtinB still have a chance and not all game over?
Ann: Investor Update Webinar, page-36
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.061M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 193633 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 165259 | 2 |
View Market Depth
| Last trade - 10.08am 01/10/2024 (20 minute delay) ? |
| NSB (ASX) Chart |
Day chart unavailable